Antisoma acquires cancer compound

Antisoma (LSE:ASM; EASD:ASOM) exercised its option to acquire Therex huHMFG1, a humanized monoclonal antibody to treat cancer, from the Imperial Cancer Research Fund. Therex is in Phase I studies to t...